Table 2 Univariate cause-specific Cox model for t-MN.

From: Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Variable

HR

95% CI1

p-value

Age

1.04

1.01–1.07

<0.01

CAR-HEMATOTOX score

1.14

0.78–1.22

0.8

MCV

1.10

1.05–1.16

<0.01

LDH

1.10

0.70–1.72

0.7

ALC

1.10

0.7–1.72

0.7

Number of prior lines

1.11

0.98–1.25

0.11

CAR T cell product (CD28 vs 41BB)

1.82

0.75–4.34

0.2

CRS grade

0.88

0.64–1.2

0.4

ICANS grade

1.32

1.01–1.74

0.04

  1. Bold values represent statistical significance p < 0.05.
Back to article page